錦勝集團(控股)(00794.HK)擬以不超1億港元出售迅興集團60%股權
格隆匯7月2日丨錦勝集團(控股)(00794.HK)宣佈,於2021年7月2日,公司間接全資附屬進高集團擬以不超1億港元向買方威隆國際集團出售目標公司迅興集團60%股權。集團擬將所得款項淨額用作經營現金流。
據悉,目標公司為於香港註冊成立之有限公司,主要從事投資控股。於公佈日期,目標公司由賣方及買方分別擁有60%及40%權益。錦勝泉州為於中國成立的有限公司,於公佈日期由目標公司全資擁有。錦勝泉州主要從事瓦楞紙板買賣及製造。
董事認為出售事項為集團重組策略的其中一環。透過出售事項,集團將能重新分配更多財務資源至其核心業務及供未來發展之用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.